S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PLX Protalix BioTherapeutics Inc

2.26

-0.07 (-3.00%)

Last Updated: 02:23:41

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Protalix BioTherapeutics Charts.

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Protalix BioTherapeutics Charts.

Protalix BioTherapeutics Inc News

Form 8-K - Current report
Wednesday 1 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 6 November 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 26 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 25 October 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 August 2024 (7 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Saturday 18 May 2024 (10 months ago) • Edgar (US Regulatory)

More Protalix BioTherapeutics Inc News Articles

Applied Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions